NEW YORK (GenomeWeb News) – As part of a new push to become a leading player in synthetic biology, the UK has provided £5.3 million ($8 million) to fund 15 new synthetic biology technology development projects at a number of companies.

The funding will fuel an array of tech development efforts at about a dozen companies. The grant winners were chosen through a competition for projects that will be led by businesses seeking to demonstrate the feasibility of using synthetic biology to create new products and processes or improve older ones.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.